Last penny stock I bought that partnered with a big pharma was HGSI when they partnered with GSK. All kinds of bashers came out and tried knocking HGSI down when it was at .50. Now look at it, 52 week high of $36.
This has the same potential but more because it's a cancer drug.
Market Data 
Markets 
AI
